Is combination therapy for malaria based on user-fees worthwhile and equitable to consumers? Assessment of costs and willingness to pay in Southeast Nigeria.

Acta Tropica
Obinna OnwujekweP Okonkwo

Abstract

To examine the equity implications of the costs of an episode of malaria, the benefit/cost ratios of using two artemisinin-based combination therapy (CT) from the consumers' view and inequities in willingness to pay (WTP) for CT. A cross-sectional survey was conducted in Southeast Nigeria, where there is a moderate to high level of malaria resistance to chloroquine and sulfadoxine-pyrimethamine formulations. WTP was elicited from respondents using the bidding game (BG) and the structured haggling technique (SH). A socio-economic status (SES) index was used to examine the level of inequity in the key variables. In the benefit/cost ratios, the average cost of CT in Nigeria and price of Coartem were, respectively, used as the cost inputs while the mean WTP was the measure of benefit. Multiple regression analyses were used to determine the validity of the WTP estimates. More than 90% of the respondents were willing to pay for CT. The mean WTP in the BG was 301.1 Naira while it was 438.0 Naira in the SH. People in the highest SES quartile (Q4) were more willing to pay for CT than the lowest SES quartile (Q1). In the regression models, the SES quartiles were significantly related to levels of WTP. The benefit/cost ratios were higher ...Continue Reading

References

Feb 6, 1997·Health Care Analysis : HCA : Journal of Health Philosophy and Policy·C DonaldsonS Macphee
Mar 16, 2000·Transactions of the Royal Society of Tropical Medicine and Hygiene·O E Onwujekwe
May 26, 2001·Journal of Health Economics·K BlumenscheinP R Freeman
Jul 27, 2001·Tropical Medicine & International Health : TM & IH·O OnwujekweP Okonkwo

❮ Previous
Next ❯

Citations

Mar 31, 2009·Transactions of the Royal Society of Tropical Medicine and Hygiene·Olakunle O KassimVictor R Gordeuk
Nov 4, 2008·Malaria Journal·Eleonor C SauloAnders Björkman
Feb 12, 2010·International Journal for Equity in Health·Benjamin Sc UzochukwuOgochukwu P Ezeoke
Oct 22, 2010·Health Research Policy and Systems·Pascale AlloteySubhash Pokhrel
Mar 13, 2008·PloS One·Benjamin S C UzochukwuMaduka D Ughasoro
Feb 2, 2017·Bulletin de la Société de pathologie exotique·S RobinE Guévart
Jun 17, 2010·PharmacoEconomics·Paul GavazaStar Khoza

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.